BTG plc (LON:BTG – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 840 ($10.66) and traded as high as GBX 840 ($10.66). BTG shares last traded at GBX 840 ($10.66), with a volume of 271,742 shares trading hands.
BTG Stock Performance
The business’s 50-day moving average price is GBX 840 and its 200 day moving average price is GBX 840. The company has a market cap of £3.26 billion and a P/E ratio of 29.47.
About BTG
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Articles
- Five stocks we like better than BTG
- Stock Market Sectors: What Are They and How Many Are There?
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- 3 REITs to Buy and Hold for the Long Term
- Progress Software Stock Back in the Green After Beating Forecasts
- How to Use Stock Screeners to Find Stocks
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.